December 23, 2020
NorthStar Healthcare Income Announces $3.89 NAV

On December 21, 2020, upon the recommendation of the audit committee (the “Audit Committee”) of the board of directors (the “Board”) of NorthStar Healthcare...

NorthStar Healthcare Income Announces $3.89 NAV

December 23, 2020

On December 21, 2020, upon the recommendation of the audit committee (the “Audit Committee”) of the board of directors (the “Board”) of NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”), the Board, including all of its independent directors, approved and established an estimated value per share of NorthStar Healthcare’s common stock of $3.89. The estimated value per share as of June 30, 2019, was $6.25. The estimated value per share is based upon the estimated value of NorthStar Healthcare’s assets less the estimated value of NorthStar Healthcare’s liabilities as of June 30, 2020, divided by the number of shares of NorthStar Healthcare’s common stock outstanding as of June 30, 2020. The change represents a 38% drop in NAV per share year-over-year. The information used to generate the estimated value per share, including market information, investment- and property-level data and other information provided by third parties, was the most recent information practically available as of June 30, 2020.

As of June 30, 2020, the estimated value of the Healthcare Properties underlying the $3.89 estimated per share value was $1.60 billion ($1.99 billion as of June 30, 2019), compared with an aggregate cost, including purchase price, deferred costs, and other assets of $2.16 billion (the “Property Purchase Price”).

As of June 30, 2020, the estimated value of the Joint Venture Investments underlying the $3.89 estimated per share value was $389.3 million, compared with an aggregate equity contribution of $511.1 million (the “Joint Venture Equity Contribution”) and an aggregate value of $488.7 million as of June 30, 2019.

Based on the above valuations and estimates and subject to the assumptions and limiting conditions contained in its report, Duff & Phelps estimated the net asset value range per fully diluted common share outstanding of NorthStar Healthcare as of June 30, 2020, from $3.38 to $4.44 per share. Based on its review of the Duff & Phelps report and the analysis of the Advisor, the Audit Committee recommended and the Board approved an estimated value per share of $3.89 as of June 30, 2020.

Share Repurchase Program

Pursuant to the terms of NorthStar Healthcare’s share repurchase program (the “SRP”), shares repurchased would be at a price equal to the lesser of the price paid for the shares, as adjusted for any stock dividends, combinations, splits, recapitalizations or any similar transaction with respect to the shares of common stock, or $3.89, the most recently published estimated value per share of NorthStar Healthcare’s common stock. In April 2020, the Board determined to suspend all repurchases under the SRP effective April 30, 2020, in order to preserve capital and liquidity.

Down From $6.25 Per Share NAV as of June 30, 2019

On December 3, 2019, upon the recommendation of the audit committee of the board of directors of NorthStar Healthcare Income, Inc., the Board, including all of its independent directors, approved and established an estimated value per share of NorthStar Healthcare’s common stock of $6.25. The estimated value per share was based upon the estimated value of NorthStar Healthcare’s assets less the estimated value of NorthStar Healthcare’s liabilities as of June 30, 2019, divided by the number of shares of NorthStar Healthcare’s common stock outstanding as of June 30, 2019.

Recent

Most Popular

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update 10-3-2023 Blue Vault wishes to acknowledge and apologize for the delay in publishing some Q2 2023 NTR Individual Performance Pages (IPPs) as well as the full review. We recently added additional reporting metrics to our IPPs, and that, combined with coverage of all share classes and some additional…
Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update 9-25-2023 Blue Vault has published the Q2 2023 Nontraded BDC Industry Review as well as Individual Performance Report and Limited Operations pages for the following offerings (newly published pages in bold font): Nontraded REITS American Healthcare REIT Q2 2023 Apollo Realty Income Solutions Q2 2023 (limited operations) Ares…

Explore

Blue Vault Logo
Don’t miss alts news
and educational events

Subscribe Now